Delivery Order SPE2DR25D1205-SPE2DR26F0WP2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $44,791.63 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on November 5, 2025, with completion scheduled for November 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its...
- The Defense Logistics Agency awarded a delivery order valued at $15,569.18 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-unit quantity) on November 13, 2025, with completion scheduled for November 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $19,847.41 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on November 5, 2025, with an ultimate completion date of November 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at the contractor's Conshohocken, Pennsylvania location. As a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $58,896.21 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on November 3, 2025, with completion scheduled for November 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $17,919.22 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on September 13, 2025, with completion expected by September 15, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $16,220.13 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with a completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded on a competitive basis. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $17,221.27 to AmerisourceBergen Drug Corp for 60-count packages of Eliquis 5 mg tablets, with an ultimate completion date of October 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,259.49 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $72,449.45 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on September 19, 2025. This competitive award, issued without a set-aside designation, carries a firm fixed price and an ultimate completion date of September 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,593.34 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0WP2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $43,150.23 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on November 12, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and maintains an extensive portfolio of federal contracts supporting military and veteran healthcare systems. This delivery order represents a task under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this arrangement, AmerisourceBergen Drug Corp serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning itself as a key supplier within the DLA's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.2k | 11/12/25 |